• Send Us A Tip
  • Calling all Tech Writers
  • Advertise
Saturday, June 21, 2025
  • Login
  • Register
TechStory
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
TechStory
No Result
View All Result
Home Business

Cambridge Startup EQRx to get an an IPO through SPAC deal

by Rohit Yadav
August 8, 2021
in Business, Markets, News, Tech, Trending
Reading Time: 2 mins read
0
Eqrx

Source: EQRX

TwitterWhatsappLinkedin

EQRx, a Cambridge startup, said on Friday that it will raise $1.8 billion by combining with a special purpose acquisition firm in order to expand its “New Pharma” platform.

You might also like

Eutelsat’s Shares Skyrocket as France Leads €1.35 Billion Investment in Satellite Future

Decade-Old Torrent Site Lands Greek Man in Prison Amid Renewed Piracy Crackdown

Residential Solar Industry Faces Major Setback as Tax Credit Cuts and Economic Pressures Threaten Future

Eqrx
Source: EQRX

SPAC was formed on the audacious assumption that it could substantially decrease medication prices, and the agreement comes less than two years later. To do so, EQRx intends to create medications for established illness targets and license projects from other firms, lowering development costs and increasing the likelihood of regulatory approval. It will also work with health systems and insurers to better understand market demands.

EQRx is valued at $3.65 billion following its merger with CM-Life Sciences III, a SPAC linked with Casdin Capital and Corvex Management.

Because it takes years to find, produce, and test new medications, they are extremely expensive.

EQRx stated in a presentation to investors that a “key assumption” about its business strategy is that its medications will be 50 to 70% less expensive than alternatives. The business also aims to have fewer program failures than traditional pharma companies, while spending less money on them.

The majority of EQRx’s projects are kept under wraps, although it did reveal that several of its late-stage therapeutic research will target cancer and inflammatory diseases. The firm claims to have ten clinical and preclinical initiatives, but it has to scale up to make its business model work. As a result, the company’s objective is to have more than 20 programs by the end of next year, and more than 50 in ten years – thus the influx of cash.

Melanie Nallicheri, president and chief operating officer of EQRx, who will take over as CEO next month, said, “We are rapidly moving toward the potential commercialization of our lead oncology programs while continuing to grow our pipeline to address the high-cost disease areas of today and tomorrow.” Alexis Borisy, a former partner of Boston venture capital company Third Rock Ventures, will become executive chairman of EQRx’s board of directors, and she will succeed her.

EQRx has raised $800 million in funding and employs about 200 employees. In the fourth quarter of this year, the merger is scheduled to be completed.

Ginkgo Bioworks, Tango Therapeutics, and Gelesis are among the local biotech businesses following the SPAC route to the public market in the Boston region. Others, such as Adagio and TScan Therapeutics, have gone for typical IPOs this year.

Despite a large number of acquisitions, George Sommer, a Boston-based partner at Deloitte, does not see signs of a SPAC-company value bubble.

Tags: EQRxEQRx IPOSPAC
Tweet54SendShare15
Previous Post

Startups, VCs requested PM Narendra Modi for direct overseas listing

Next Post

Nasdaq’s initiative on corporate boards approved by SEC

Rohit Yadav

Hi! I'm Rohit, If you like reading about markets, technology and business, you've come to the right place. Catch me: [email protected]

Recommended For You

Eutelsat’s Shares Skyrocket as France Leads €1.35 Billion Investment in Satellite Future

by Harikrishnan A
June 21, 2025
0
Eutelsat’s Shares Skyrocket as France Leads €1.35 Billion Investment in Satellite Future

Eutelsat, the European satellite company, made headlines this week as its stock surged an impressive 31% on Friday. The rally came right after the company announced it had...

Read more

Decade-Old Torrent Site Lands Greek Man in Prison Amid Renewed Piracy Crackdown

by Harikrishnan A
June 21, 2025
0
Decade-Old Torrent Site Lands Greek Man in Prison Amid Renewed Piracy Crackdown

In a courtroom in Piraeus, Greece, silence quickly turned to shock when three police officers stepped forward, handcuffed a 59-year-old man, and led him away. Moments earlier, the...

Read more

Residential Solar Industry Faces Major Setback as Tax Credit Cuts and Economic Pressures Threaten Future

by Harikrishnan A
June 21, 2025
0
Residential Solar Industry Faces Major Setback as Tax Credit Cuts and Economic Pressures Threaten Future

Once seen as a shining symbol of clean energy progress in the U.S., the residential solar industry is now battling to stay afloat. Just a few years ago,...

Read more
Next Post
Amazon

Nasdaq's initiative on corporate boards approved by SEC

Please login to join discussion

Techstory

Tech and Business News from around the world. Follow along for latest in the world of Tech, AI, Crypto, EVs, Business Personalities and more.
reach us at [email protected]

Advertise With Us

Reach out at - [email protected]

BROWSE BY TAG

#Crypto #howto 2024 acquisition AI amazon Apple bitcoin Business China cryptocurrency e-commerce electric vehicles Elon Musk Ethereum facebook flipkart funding Gaming Google India Instagram Investment ios iPhone IPO Market Markets Meta Microsoft News NFT samsung Social Media SpaceX startup startups tech technology Tesla TikTok trend trending twitter US

© 2024 Techstory.in

No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to

© 2024 Techstory.in

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?